Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy

Archives of Ophthalmology

Volumn 116, Issue 3, 1998, Pages 351-358

  Votmba, M ^a,c   Fitzke, V ^a,b   Holder, G E ^a,b   Carter, A ^a,b   Bhattacharya, S S ^a   Moore, A T ^a,b  

^a Molecular Genetics   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 3Q; DISEASE SEVERITY; EVOKED VISUAL RESPONSE; FEMALE; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; OPTIC NERVE ATROPHY; PEDIGREE ANALYSIS; PERIPHERAL VISION; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 0031915967     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.3.351     Document Type: Article

References (51)

1. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol. 1959;37(suppl 54):1-146.
2. Eliott MD. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993:115:360-367.
3. Batten B. A family suffering from hereditary optic atrophy. Trans Ophthalmol Soc U K.1896;16:125.
4. Caldwell JBH, Howard RO, Riggs LA. Dominant juvenile optic atrophy: a study of two families and review of the hereditary disease in childhood. Arch Ophthalmol. 1971:85:133-147.
5. Smith DP. Diagnostic criteria in dominantly inherited juvenile optic atrophy: a report of three new families. Am J Optom Physiol Opt. 1972;49:183-200.
6. Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology. 1980:87:245-251.
7. Jaeger W. Diagnosis of dominant infantile optic atrophy in early childhood. Ophthalmic Pediatr Genet. 1988:9:7-11.
8. Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979:97:1680-1686.
9. Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathological study of autosomal dominant optic atrophy. Am J Ophthalmol. 1979:88:868-875.
10. Kjer P. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol. 1982:61:300-312.
11. Harding GFA, Crews SJ, Pitts SM. Psychophysical and visual evoked potential findings in hereditary optic atrophy. Trans Ophthalmol Soc U K. 1979:99:96-102.
12. Berninger TA, Jaeger W, Krastel H. Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br J Ophthalmol. 1991:75:49-52.
13. Holder GE. Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol. 1987;71:166-171.
14. McKusick VA. Mendelian Inheritance in Man. 10th ed. Baltimore, Md: Johns Hopkins University Press; 1992.
15. Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1 ) mapped to . chromosome 3q region, I: linkage analysis. Hum Mol Genet. 1994:3:977-980.
16. Bonneau D, Souied E, Gerber S, et al. No evidence of genetic heterogeneity in dominant optic atrophy. J Med Genet. 1995:32:951 -953.
17. Brown J, Fingert JH, Taylor CM, Lake M, Sheffield VC, Stone EM. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1 ). Arch Ophthalmol. 1997:115:95-99.
18. Johnston RL, Surdon MA, Spalton DJ, Bryant SP, Behnam JT, Seller MJ. Dominant optic atrophy, Kjer type: linkage analysis and clinical features in a large British pedigree. Arch Ophthalmol. 1997:115:100-103.
19. Kivlin JD, Lovrien EW, Bishop DT, Maumenee IH. Linkage analysis in dominant optic atrophy. Am J Hum Genet. 1983:35:1190-1195.
20. Jonasdottir A, Eiberg H, Kjer B, Kjer P, Rosenberg T. Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q283q29, within a 3-Mb YAC contig. Hum Genet. 1997:99:115-120.
21. Votruba M, Moore AT, Bhattacharya SS. Genetic refinement of dominant optic atrophy (OPA1 ) locus to within a 2cM interval of chromosome 3q. J Med Genet. 1997;34:117-121.
22. Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region, II: clinical and epidemiological aspects. Ada OphthalmolScand. 1996;74:3-7.
23. Lunkes A, Härtung U, Magarino C. Refinement of the OPA1 gene locus on chromosome 3q28-q29 to a region of 2-8 centimorgans in one Cuban family with autosomal dominant optic atrophy type Kjer. Am J Hum Genet. 1995;57:968-970.
24. Wu D, Bird AC, McNaught A, Buckland MS, Fitzke FW. Fine matrix mapping of the macular region in normal subjects. Chung Hua Yen Ko Tsa Chih. 1995;31:243-249.
25. Westcott MC, McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. High spatial resolution automated perimetry in glaucoma. Br J Ophthalmol. 1997;81:452-459.
26. Fitzke FW, Poinoosawmy D, Ernst W, Hitchings FIA. Peripheral displacement thresholds in normals, ocular hypertensives and glaucoma. In: Grève EL, Heijl A, eds. Seventh International Visual Field Symposium, Amsterdam, September 1986, Documenta Ophthalmologica Proceedings Series. Dordrecht, the Netherlands: Kluwer Academic Publishers Group; 1987;49:447-452.
27. Leventhal AG, Rodieck RW, Dreher B. Retinal ganglion cell classes in the old world monkey: morphology and central projections. Science. 1981;213:1139-1142.
28. Livingstone MS, Hubel DH. Segregation of form, colour, movement and depth: anatomy, physiology and perception. Science. 1988;240:740-749.
29. Mollon JD, Astell S, Reffin JP. A minimalist test of colour vision. In: Drum B, Moreland JD, Serra A, eds. Colour Vision Deficiencies. Vol 10. Dordrecht, the Netherlands: Kluwer Publishers; 1991:59-67.
30. Harding GFA, Odom JV, Spileers W, Spekreijse H. Standard for visual evoked potentials 1995. Vision Res. 1996;36:3576-3572.
31. Marmor MF, Holder GE, Porciatti V, Trick G, Zrenner E. Guidelines for pattern electroretinography: recommendations by the International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol. 1996;91:291-298.
32. BerningerT, Arden GB.The pattern electroretinogram. In: HeckenlivelyJR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology ol Vision. SI Louis, Mo: Mosby-Year Book; 1991:291-300.
33. Votruba M, Bnattacharya SS, Moore AT. No evidence for genetic heterogeneity in autosomal dominant optic atrophy. Vision Res. 1995;35:S240. Abstract.
34. Votruba M, Bhattacharya SS, Moore AT. Autosomal dominant optic atrophy (OPA): linkage of British pedigrees and refinement of the locus. Invest Ophthalmol Vis Sei. 1996;37:5656. Abstract.
35. Holder GE. Pattern ERG in evaluation of glaucoma and optic nerve function. In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision. St Louis, Mo: Mosby-Year Book; 1991:549-556.
36. Bach M, Gerling J, Geiger K. Optic atrophy reduces the pattern electroretinogram for both fine and coarse stimulus patterns. Clin Vision Sei. 1992;7:327-334.
37. Vaegan, Billson FA. The differential effect of optic nerve disease on pattern and focal electroretinograms. Doc Ophthalmol. 1987;65:45-56.
38. Rodieck RW. Which cells code for color? In: Valberg A, Lee BB, eds. From Pigments to Perception. New York, NY: Plenum Press; 1991:83-93.
39. Bullimore MA, Wood JM, Swenson K. Motion perception in glaucoma. Invest Ophthalmol Vis Sci. 1993;34:3526-3533.
40. Fitzke FW, Poinoosawmy D, Nagasubramanian S, Hitchings R. Peripheral displacement thresholds in glaucoma and ocular hypertension. Perimetry Update. 1988;198:399-405.
41. Manchester PT, Calhoun FP. Dominant hereditary optic atrophy with bitemporal field defects. Arch Ophthalmol. 1958;60:479-484.
42. Freund C, Horsford DJ, Mclness RR. Transcription factor genes and the developing eye: a genetic perspective. Hum Mol Genet. 1996;5:1471-1488.
43. Feder JN, Li L, Jan LY, Jan YN. Genomic cloning and chromosomal localization of HRY, the human homolog to the drosophila gene, hairy. Genomics. 1994;20:56-61.
44. Tomita K, Ishibashi M, Nakahara K, et al. Mammalian hairy and enhancer of Split homolog-1 regulates differentiation of retinal neurons and is essential for eye morphogenesis. Neuron. 1996;16:723-734.
45. Ishibashi M, Ang SL, Shiota K, Nakanishi S, Kageyama R, Guillemont F. Targeted disruption of mammalian hairy and enhancer of Split homolo-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev. 1995;9:3136-3148.
46. Xiang M, Zhou H, Nathans J. Molecular biology of retinal ganglion cells. Proc Nat/ Acad Sei U S A 1996;93:596-601.
47. Xiang M, Zhou L, Macke J, et al. The Brn-3 family of POU-domian factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci. 1995;15:4762-4785.
48. Gan L, Xiang M, Zhou L, Wagner DS, Klein WH, Nathans J. POL) domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc Natl Acad Sci U S A. 1996:93:3920-3925.
49. Xiang M, Zhou L, Peng Y, et al. The gene for Brn-3b: a POU domain protein in retinal ganglion cells is assigned to the q31.2 region of chromosome 4. Cytogenet Cell Genet. 1993;93:7. Abstract.
50. Rice DS, Williams RW, Davisson MT, Harris B, Goldowitz D. A new mutant phenotype of retinal ganglion cell dysgenesis discovered in the mouse. Soc Neurosci Abstr. 1993:19:51. Abstract.
51. Rice DS, Williams RW, Ward-Bailey P, et al. Mapping the Bst mutation on mouse chromosome 16: a model for human optic atrophy. Mammalian Genome. 1995; 6:546-548.